4baseCare Raises $6 Million in Series A Funding led by Yali Capital

4baseCare, an Illumina Accelerator Company, that offers cutting-edge precision oncology solutions using advanced genomics and digital health technology, has raised $6 million in Series A funding led by Yali Capital and other investors. The funding will be used to enhance product offerings and scaling up operations for further expansion across India, as well as other countries in Asia and the Middle East.

4baseCare has previously raised about $3.3 Million in funding led by Mount Judi Ventures and participated by GrowX ventures, Season Two Ventures, First In Ventures, and other angel investors.

Commenting on the investment, Mathew Cyriac, Founding General Partner, Yali Capital said, “The genomics landscape in cancer care offers a tremendous opportunity to create impactful businesses while improving millions of lives. As a deep tech focused fund, we are particularly excited about 4baseCare’s ability to enhance genomic tests with data from underrepresented populations, leading to improved treatment recommendations. 4baseCare has demonstrated impressive growth over the last few years, and we look forward to helping the team build a sustainable and profitable business.

Commenting on the fundraise, Hitesh Goswami, CEO and Co-Founder, 4baseCare, said, “4baseCare was founded with an aim to address the critical genomic data gap in cancer care. Our journey from developing TARGT Indiegene to impacting the lives of over 10,000 patients has been a very fulfilling experience. The success of our test and our growth over the years is a result of the exceptional support from our investors and the invaluable insights from our advisory board. This funding will further enable us to enhance our product offerings and advance our mission of making personalized cancer care accessible to millions”
Over the next few months, 4baseCare will set up genomics laboratories in the Philippines, Nepal, and Dubai. Additionally, they will focus on building genomics and digital health solutions, focusing on advanced data analytics, improved clinical insights, and data-driven treatment recommendations.